Visitors must have compliant masks

Oregon is continuing to prioritize phase 1a, which includes health care personnel, residents in long-term care or treatment programs and certain other high-risk individuals.

While the COVID-19 vaccine is critical to stopping the pandemic, it is not the only effort.

Black birthing patients in the U.S. are 4 to 5 times more likely to die in childbirth than their white counterparts

Providence Multiple Sclerosis Center, in partnership with leading African American neurologists across the United States, has launched a first-of-its-kind effort to identify Black people with MS.

Family physicians are crucial partners in the battle against lung cancer.

Providence Heart Institute has performed five heart transplants since July, with plans to perform up to 12 transplants by summer 2021.

Providence Cancer Institute is the only center in the Pacific Northwest to offer a groundbreaking study of adoptive T-cell therapy ADP-A2M4 in combination with the checkpoint inhibitor pembrolizumab.

As the COVID surge continues, we are returning to our regionwide visitation policy of one visitor per patient stay.

Due to the dramatic surge in COVID cases over the past few weeks, there will be temporary limits on surgeries and invasive procedures starting Dec. 3.

Read a message from Providence clinical leaders, both in Oregon and at the system level, about the importance of staying home and celebrating Thanksgiving with members of your household.

Being a provider or other member of the care team requires years of training, sometimes long hours, and emotional conversations with patients and their families.

Providence Cancer Institute now offers radiation treatments using the latest technology called the MR Linac, which uses MRI-guided radiation that can be modified in real time for pinpoint accuracy.

Providence Multiple Sclerosis Center, in partnership with leading African American neurologists across the United States, has launched a first-of-its-kind effort to identify Black people with MS.

Patients now have access to an experienced, specialized team in gynecologic oncology as part of Providence Cancer Institute.

Caring for patients, while also caring for ourselves, can be challenging.

The U.S. Food and Drug Administration has granted Providence Cancer Institute researchers approval to begin a first-in-human clinical trial of a vaccine to protect against COVID-19.

COVID cases are skyrocketing in our communities. We need to make immediate changes to keep each other and our patients safe.